2024³â º½ Çмú´ëȸ°¡ 4¿ù 5ÀÏ~6ÀÏ ÆÇ±³ Â÷¹ÙÀÌ¿ÀÄÄÇ÷º½º¿¡¼ °³ÃֵǾú½À´Ï´Ù. ħ»ù, ¸²ÇÁÀý, ºÎÀΰú ¼¼Æ÷º´¸®¸¦ ÁÖÁ¦·Î ÇÏ¿´À¸¸ç ¸ðµÎ 672¸íÀÌ µî·ÏÇÏ¿´½À´Ï´Ù (Àü¹®ÀÇ 424¸í, Àü°øÀÇ 25¸í, ¼¼Æ÷º´¸®»ç 223¸í).
Ư° ¹× ½ÉÆ÷Áö¿ò ³»¿ëÀº ´ÙÀ½°ú °°½À´Ï´Ù.
1) Ư°1
WHO reporting systems in cytopathology, their rationale, process and progress so far: Andrew Field (University of NSW and Notre Dame University Medical School & St Vincent¡¯s Hospital)
2) ½ÉÆ÷Áö¾ö IA: Salivary gland cytology
- Key diagnostic points in differential diagnoses of common salivary gland tumors: ½Å¼öÁø(¿¬¼¼ÀÇ´ë)
- Updates in salivary gland cytology: ¼ÛÁؼ±(¿ï»êÀÇ´ë)
3) ½ÉÆ÷Áö¾ö IB: Lymph node cytology
- What to see in diagnosing lymph node cytology: Á¶ÀÇÁÖ(°¡Å縯ÀÇ´ë)
- Practical issues of ancillary studies in hematolymphoid cytology: Focused on cell block IHC: ÃÖ¼®Áø(ÀÎÇÏÀÇ´ë)
4) ¼¼Æ÷ Áø´ÜÀ» À§ÇÑ º´¸® ±³À° ÇÁ·Î±×·¥
¼¼Æ÷ Áø´ÜÀ» À§ÇÑ Ä§»ù Á¾¾çÀÇ Á¶Á÷º´¸®: ÃßÁø¾Æ(¼º±Õ°üÀÇ´ë)
5) Ư°2
Molecular cytopathology: Fernando Schmitt (Medical Faculty of Porto University)
6) ½ÉÆ÷Áö¾ö II: Gynecologic cytology
- Cervical cancer screening: PAP vs. HPV: À̾ƿø(°¡Å縯ÀÇ´ë)
- HSIL with features suspicious of invasion and invasive squamous cell carcinoma: retrospective analysis with histologic correlation: ¿ìÇÏ¿µ(Áß¾ÓÀÇ´ë)
Panel discussion¿¡¼´Â ¡°Application of WHO reporting systems in daily practice¡±, ¡°Cervical cancer screening: where we are and where we should go¡±À» ÁÖÁ¦·Î ÇÏ¿© Ȱ¹ßÇÑ Åä·ÐÀÌ ÀÌ·ç¾îÁ³½À´Ï´Ù.
¿ì¼ö±¸¿¬»ó/½½¶óÀ̵弼¹Ì³ª Áõ·Ê ÃÊ·Ï»ó ½Ã»ó¿¡¼ ÃÖ¿ì¼ö ±¸¿¬»ó¿¡´Â ¹ÚÇýÀº(º¸¶ó¸Åº´¿ø),
¿ì¼ö±¸¿¬»ó¿¡´Â Á¤Çý¶ó(°è¸íÀÇ´ë) ±èÇöÁ¤(»ó°è¹éº´¿ø) Á¶ÀÇÁÖ(¼ººó¼¾Æ®º´¿ø) ȸ¿øÀÌ ¼ö»óÇÏ¿´°í,
¿ì¼öE-Æ÷½ºÅÍ»óÀº ¼Õ°æÈñ(¼¿ï¾Æ»êº´¿ø),
½½¶óÀ̵弼¹Ì³ª Áõ·Ê ¿ì¼ö ÃÊ·Ï»óÀº È«¿ø±â(¼¿ï¾Æ»êº´¿ø) ȸ¿øÀÌ ¼ö»óÇÏ¿´½À´Ï´Ù.